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Abstract: An der Klinik für Kleintiermedizin der Vetsuisse-Fakultät Zürich wurde kürzlich eine neue
Methode zur Kapillarblutgewinnung am Ohr von Hunden und Katzen mittels einer speziellen Stech-
hilfe (Microlet Vaculence ?, Bayer Diagnostics) entwickelt. Im ersten Teil dieser Studie wurden die
Brauchbarkeit der Methode zur Anwendung durch Besitzer und mögliche technische Probleme untersucht.
Die Besitzer von 7 gesunden Hunden und 7 gesunden Katzen wurden gebeten, zwei Blutglukosekurven
(Messen von Blutglukosewerten alle 2 Stunden für 12 Stunden) zu erstellen. Allen Hundebesitzern und
3 Katzenbesitzern war es möglich zuverlässige Glukosekurven herzustellen. Zu den häufigsten Proble-
men zählten, ein ungenügend grosser Blutstropfen durch zu starken Fingerdruck auf die Ohrmuschel,
wiederholtes Runterdrücken des Auslösers der Stechhilfe anstatt einem langsamen Vakuumaufbau und
Nichtfüllen des Teststreifens bis zur Markierung. Schlussfolgerung war, dass diese Schritte während der
technischen Demonstration gezielt hervorgehoben werden müssen. Der zweite Teil der Studie hatte zum
Ziel die Durchführbarkeit der Glukosemessung zu Hause bei diabetischen Hunden und Katzen durch die
Besitzer über eine längere Periode zu testen, die aufkommenden Probleme zu eruieren, und die Blut-
glukosekurven von zu Hause mit denen am Spital zu vergleichen. Besitzer von 12 diabetischen Hunden
und 15 diabetischen Katzen mussten mittels der Kapillarblutmethode am Ohr vier Glukosekurven, jew-
eils mit 3-4 Wochen Abstand, erstellen. Innerhalb 1 Woche nach der Erstellung der Kurve zu Hause,
wurde eine zusätzliche Kurve am Spital angefertigt. Zehn Hunde- und 12 Katzenbesitzern gelang es Blut-
glukosekurven über die Studienzeit von vier Monaten zu erstellen. Die meisten Probleme entstanden bei
der Herstellung des negativen Drucks durch die Stechhilfe, beim Produzieren des Blutstropfens und beim
Festhalten des Tieres. In den meisten Fällen konnten diese Probleme im Laufe der Studie gelöst werden.
Die Blutzuckerwerte in der Klinik waren tendenziell tiefer als die Werte zu Hause. In 42 % der Hunde und
38 % der Katzen wäre eine Therapieänderung aufgrund der Kurven im Spital unterschiedlich als aufgrund
der Kurven zu Hause ausgefallen. Die Resultate dieser Studie zeigen, dass die Mehrheit der Tierbesitzer
fähig und willens ist Heimmonitoring des Blutglukosespiegls über eine längere Periode durchzuführen und
dass die Methode als Unterstützung beim Management von diabetischen Hunden und Katzen geeignet
ist. Es wird angenommen, dass Glukosemessungen zu Hause zuverlässiger sind als im Spital gemessene
Werte und dass Heimmonitoring deshalb hilft falsche Therapieentscheidungen zu vermeiden. Recently a
new method for capillary blood sampling from the ears of dogs and cats using a lancing device (Microlet
Vaculence â, Bayer Diagnostics) has been developed in the Clinic for Small Animal Internal Medicine,
University of Zurich. In the first part of the present study the suitability of this method for use by pet
owners and the potential technical problems were evaluated. The owners of seven healthy dogs and seven
healthy cats were asked to perform two glucose curves (measuring blood glucose concentration every 2
hours for a total of 12 hours). All dog owners and three cat owners were able to perform a reliable blood
glucose curve. The most frequently encountered problems were inadequate formation of blood drop due
to excessive digital pressure on the pinna, repeatedly depressing the plunger of the lancing device instead
of allowing the negative pressure to slowly build up, and failure to fill the test strip up to the mark. It was
concluded that these steps of the procedure need to be stressed during technique demonstration. In the
second part of the study, the objective was to investigate the feasibility of monitoring blood glucose at
home in diabetic dogs and cats by owners on a long term basis, the problems encountered and to compare
glucose concentrations at home with those measured in the hospital. Owners of 12 diabetic dogs and of
15 diabetic cats were asked to generate 4 glucose curves by means of capillary blood sampling from the
ear spaced 3 - 4 weeks apart. Within 1 week after each curve an additional curve was performed in the
hospital. Ten dog and 12 cat owners were able to generate blood glucose curves over the study period of
4 months. Most problems were related to generating negative pressure with the lancing device and pro-
ducing a blood drop, and to restrain the pet. In the majority of cases, these problems could be resolved
during the study. Blood glucose concentrations in the clinic tended to be lower than at home. Overall
in 42% of cases in dogs and in 38% of cases in cats, treatment based on hospital curves would have been
different than that based on home curves. The results of these studies demonstrate that the majority of
pet owners are able and willing to perform long-term monitoring of blood glucose concentration and that
home monitoring of blood glucose concentrations may serve as a new tool in the management of diabetic
dogs and cats. It is assumed that glucose measurements at home are more reliable than those measured
in the hospital and that home monitoring helps to prevent false treatment decisions.
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Home monitoring of blood glucose by owners of diabetic cats and dogs: technical problems 
and evaluation of differences between home and hospital blood glucose curves. 
 
Recently a new method for capillary blood sampling from the ears of dogs and cats using a 
lancing device (Microlet Vaculence , Bayer Diagnostics) has been developed in the Clinic for 
Small Animal Internal Medicine, University of Zurich. 
In the first part of the present study the suitability of this method for use by pet owners and the 
potential technical problems were evaluated. The owners of seven healthy dogs and seven 
healthy cats were asked to perform two glucose curves (measuring blood glucose concentration 
every 2 hours for a total of 12 hours). All dog owners and three cat owners were able to perform 
a reliable blood glucose curve. The most frequently encountered problems were inadequate 
formation of blood drop due to excessive digital pressure on the pinna, repeatedly depressing the 
plunger of the lancing device instead of allowing the negative pressure to slowly build up, and 
failure to fill the test strip up to the mark. It was concluded that these steps of the procedure need 
to be stressed during technique demonstration.  
In the second part of the study, the objective was to investigate the feasibility of monitoring 
blood glucose at home in diabetic dogs and cats by owners on a long term basis, the problems 
encountered and to compare glucose concentrations at home with those measured in the hospital. 
Owners of 12 diabetic dogs and of 15 diabetic cats were asked to generate 4 glucose curves by 
means of capillary blood sampling from the ear spaced 3 - 4 weeks apart. Within 1 week after 
each curve an additional curve was performed in the hospital. Ten dog and 12 cat owners were 
able to generate blood glucose curves over the study period of 4 months. Most problems were 
related to generating negative pressure with the lancing device and producing a blood drop, and 
to restrain the pet. In the majority of cases, these problems could be resolved during the study. 
Blood glucose concentrations in the clinic tended to be lower than at home. Overall in 42% of 
cases in dogs and in 38% of cases in cats, treatment based on hospital curves would have been 
different than that based on home curves.  
The results of these studies demonstrate that the majority of pet owners are able and willing to 
perform long-term monitoring of blood glucose concentration and that home monitoring of blood 
glucose concentrations may serve as a new tool in the management of diabetic dogs and cats. It 
is assumed that glucose measurements at home are more reliable than those measured in the 
hospital and that home monitoring helps to prevent false treatment decisions.  
The work has been published (respectively submitted for publication) in the following journals: 
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Measurement of Capillary Blood Glucose
Concentrations by Pet Owners: A New Tool
in the Management of Diabetes Mellitus
Recently a new method for capillary blood sampling from the ears of dogs and cats was
described, which allows the measurement of glucose concentration by means of portable glucose
meters. The authors of this report evaluated the suitability of this method for use by pet owners
and the potential technical problems. The owners of seven healthy dogs and seven healthy cats
were asked to perform two glucose curves (measuring blood glucose concentration every 2
hours for a total of 12 hours). All dog owners and three cat owners were able to perform a reliable
blood glucose curve. The most frequently encountered problems were inadequate formation of a
blood drop due to excessive digital pressure on the pinna, repeatedly depressing the plunger of
the lancet device instead of allowing the negative pressure to slowly build up, and failure to fill the
test strip up to the mark. The authors conclude that these steps of the procedure need to be
stressed during technique demonstration and that home monitoring of blood glucose concentra-
tions may serve as a new tool in the management of diabetic dogs and cats.
J Am Anim Hosp Assoc 2002;38:239-245.
Martina Casella, DVM
Gerhard Wess, DVM
Claudia E. Reusch, DVM, PhD,
Diplomate ECVIM
Introduction
Determination of blood glucose concentrations and serial blood glucose
curves are important aspects of long-term management of diabetic dogs
and cats. These measurements are used to assess insulin efficacy, the
glucose nadir, and the duration of effect of insulin, thereby serving as a
basis for modifications in insulin therapy.1-4
Historically, blood collection for determination of glucose concentra-
tion has been performed predominantly by a veterinarian, because own-
ers are not skilled at venipuncture. However, this is time consuming and
expensive for the owner and may affect the blood glucose concentration,
as the pet may be stressed in an unfamiliar environment and be reluctant
to eat.5,6
In contrast, many human diabetics perform home monitoring of
blood glucose concentrations using a portable blood glucose meter
(PBGM) and capillary blood, which is collected by pricking a fingertip
with a lancet device.7,8 It has been determined that home monitoring of
blood glucose concentrations by human diabetics results in optimization
of metabolic control.9 However, it has also been shown that problems
related to blood collection and incorrect use of the PBGM do occur with
home monitoring. This can result in erroneous blood glucose measure-
ments, undue changes in treatment, and loss of motivation of the
patient.10 Thus, basic training followed by periodic reassessment of the
technique is of utmost importance.11-17
In a recent study, the authors demonstrated the feasibility of the col-
lection of capillary blood from dogs and cats using a lancet device
designed for humans.18 In all animals, enough blood from the inner
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aspect of the ear was collected by the same veterinarian for
determination of blood glucose concentration using a
PBGM. In addition, it was shown that there was good
agreement between the glucose concentration of capillary
blood and that of venous blood.18 The results of this study
suggested that this technique may be suitable for use at
home by owners of diabetic companion animals.
The goals of the present study were to evaluate whether
pet owners are able to collect capillary blood and perform
glucose measurements at home, and to investigate what types
of technical problems may arise during these procedures.
Materials and Methods
Animals
The animals used were client owned and consisted of seven
healthy dogs and seven healthy cats. The dogs ranged in
age from 2 to 10 years (median, 5 years) and were com-
prised of five spayed females and two intact males. The cats
ranged in age from 6 months to 10 years (median, 2 years)
and were comprised of three spayed females, three cas-
trated males, and one intact male. Animals were chosen for
inclusion into the study when owners were unfamiliar with
any kind of blood collection but were willing to learn capil-
lary blood sampling. The study was approved by the veteri-
nary authorities of the Canton of Zurich.
Study Design
In all animals, the results of clinical, hematological, and
serum biochemical evaluations were within reference
ranges. The methods for collection of capillary blood from
the ear using a lancet device and measurement of blood glu-
cose concentration using a PBGM were both explained and
demonstrated to the pet owners individually. The owners
then performed one or two blood collections with the clini-
cian present. The entire instruction lasted about 30 minutes.
The owners were then given a lancet device,a a PBGM,b
two forms for recording blood glucose concentrations, and
two questionnaires assessing owner experience with the
technique. They were asked to perform two blood glucose
curves by determining the blood glucose concentration
every 2 hours for a total of 12 hours (i.e., consisting of
seven blood collections). The second blood glucose curve
was performed 1 to 2 weeks after the first. The days on
which the first and second blood glucose curves were deter-
mined were designated as days 1 and 2, respectively. The
blood glucose measurements were recorded, and the ques-
tionnaire was filled in after each blood glucose curve.
Those owners who were not able to collect blood at home
received a second instruction in the clinic.
Blood Collection and Blood Glucose Concentration
Measurement Technique
This technique has been previously described19 and is
shown in Figure 1. Briefly, the tip of the ear was held
between the thumb and index finger (it was left to the dis-
cretion of the owner as to which ear pinna to use), and the
entire surface of the outer pinna was held flat using the
remaining fingers of the same hand. With the other hand,
the lancet device was lightly placed on a nonhaired area of
the pinna so that an airtight seal was formed between the
endcap of the device and the skin. When the plunger cap of
the instrument was pressed, a lancet moved quickly back
and forth once. Pressure between the endcap and the skin
was maintained while the plunger was slowly released. The
skin of the ear began to slightly bulge up into the endcap,
because of the developing negative pressure. The formation
of a drop of blood was hastened by releasing the pressure
that was exerted on the surface of the pinna by those fingers
holding the pinna in a flat position. When an adequate
amount of blood appeared on the skin, which was visible
through the transparent endcap, the plunger was pressed
down to release the negative pressure, and the lancet device
was removed. Then the test strip in the PBGM was brought
into contact with the blood drop, and the required amount
of blood was automatically drawn onto the test strip. The
concentration of blood glucose was shown on the PBGM
display 29 seconds later. The owners were instructed to
warm the ear by rubbing it or to change the lancet in the
lancet device when an insufficient amount of blood was
obtained. Usually the same lancet was used to perform a
blood glucose curve (i.e., for seven blood glucose measure-
ments); the lancet was cleaned in between when needed.
The PBGM was calibrated before it was given to the
owner, and further calibration during the study was deemed
unnecessary. The owners were shown how to perform a
control measurement with a control test strip and were
encouraged to do this prior to the blood glucose curve on
each day.
Questionnaire
There were a total of 18 questions divided into seven sec-
tions that related to the following aspects of blood collection
and glucose measurements: restraint of the animal, genera-
tion of a vacuum with the lancet device, generation of a drop
of blood, absorption of blood onto the PBGM test strip,
overall use of the equipment, patient tolerance of the proce-
dure, and judgment regarding its feasibility.
Statistical Analysis
All results were analyzed by means of parameter-free statis-
tical methods.c Ranges and median values are given. The
Mann-Whitney-U-Test was used to determine differences.
Differences were considered significant at P<0.05.
Results
Dogs
Four of the seven owners completed both blood glucose
curves without additional instruction. One of these four
owners reported having no problems during the entire
study. The problems encountered most frequently by the
other three owners were generation of negative pressure
with the lancet device (n=2), generation of a drop of blood
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(n=2), and handling of the PBGM (n=1). However, after
repeated attempts they were able to overcome these difficul-
ties on their own. The remaining three owners were unable
to obtain a blood glucose measurement on the first day
because of technical problems, which included inability to
generate negative pressure with the lancet device (n=1) and
inadequate absorption of the blood drop (n=2). The problem
with the generation of negative pressure was due to incorrect
use of the lancet device. Instead of allowing the negative
pressure to slowly build after depressing and releasing the
plunger once, this owner had repeatedly depressed the
plunger. Additionally, the negative pressure was inadequate
because the owner failed to reduce the pressure exerted by
the fingers on the surface of the pinna. The problem with the
absorption of the blood drop was due to the erroneous
attempt to drop the blood onto the test strip rather than
allowing the blood to be absorbed automatically by the strip.
This resulted in an inadequate amount of blood for correct
measurement by the PBGM. Additional technical problems
that were experienced by those owners who were unable to
obtain a measurement on day 1 were failure to produce an
adequate amount of blood (n=1) and inadequate restraint of
the dog (n=1). The problems were identified during a second
consult. After the technique was explained and demonstrated
a second time, these three owners were able to perform the
second blood glucose curve without difficulty.
With respect to the whole group, patient resistance to the
blood collection technique was shown on day 1 during gen-
eration of a negative pressure (n=4), lancing of the skin
(n=3), and restraint (n=1). On day 2, less negative reactions
were recorded; they appeared during generation of a nega-
tive pressure (n=3) and lancing of the skin (n=1). Generally,
the dogs tolerated the procedure well. On day 1, a second
person was required to restrain three of the dogs, whereas
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Figures 1A-1D—Blood collection technique. (1A) The tip of the ear is held between the thumb and index finger, and the
surface of the pinna is held flat by the rest of the fingers. Then the lancet device is set on a nonhaired area of the ear. (1B)
An airtight seal between the device and ear is obtained by pushing the outer ear against the device with the tip of one fin-
ger. (1C) The lancet is activated by pressing the plunger cap of the device. With slow release of the plunger cap, a negative
pressure is created, and the skin slightly bulges up into the endcap. The negative pressure is maintained until there is an
adequate amount of blood. (1D) The portable blood glucose meter (PBGM), with the test strip inserted, is placed over the
drop of blood. The blood is automatically absorbed, and after 29 seconds the blood glucose concentration is displayed.
A B
C D
the other four owners were able to collect blood and operate
the PBGM alone. Two of the latter reported having minor
problems with the restraint of their dogs. On day 2, a sec-
ond person was required to restrain one dog only. The inci-
dences of technical problems encountered in dogs are
reported in Table 1.
Operation of the PBGM generally was not a problem for
owners. Four had difficulty coordinating the positioning of
the ear and placing the test strip in the PBGM to allow
absorption of the blood onto the test strip. The control
measurements were performed without difficulty by all of
the owners prior to the blood glucose curve on each day;
the results were always within the reference range. Overall
procedure assessment is provided in Table 2.
Cats
Two of the seven owners were able to perform both blood
glucose curves without additional instruction. One other
owner was unable to perform the first blood glucose curve.
The problem was due to insufficient generation of negative
pressure because of incorrect use of the lancet device
(repeated depression of plunger as in the above-mentioned
dog). However, after the procedure was explained and
demonstrated a second time and the help of a second person
was obtained to restrain the cat, this owner completed the
second blood glucose curve.
The procedure could not be performed by the remaining
four owners. Two of the four cats resisted restraint through-
out the entire study, and blood could not be collected for
any blood glucose determination. This was attributed to
poor tolerance of the procedure, even with a second per-
son’s help in restraining the animal. The other two of the
four cats tolerated collection of blood only sporadically, so
a complete blood glucose curve was not possible. In one of
those two cases, bilateral aural hematomas developed,
which made the generation of a blood drop impossible. The
second cat became fractious after several unsuccessful
attempts to collect blood and subsequently did not tolerate
the procedure. Additional problems encountered by these
two cat owners included inability to generate negative pres-
sure using the lancet device (n=1) and inability to obtain an
adequate amount of blood (n=1).
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Table 1
Technical Problems During the Determination of Blood Glucose Concentration in Seven Dogs
Incidence of Technical Problem*
Never† Sometimes‡ Often§ Always\
Technical Problem Day 1 Day 2 Day 1 Day 2 Day 1 Day 2 Day 1 Day 2 
1. Restraint required 4 3 2 3 - - 1 1
Repeated punctures required 3 4 3 2 1 1 - -
Resistance to procedure 2 3 4 3 - - 1 1
2. Vacuum generation - 2 2 3 4 2 1 -
Repeated punctures required - 2 5 5 2 - - -
Accidental repeated punctures 7 7 - - - - - -
3. Blood drop generation - 4 2 3 4 - 1 -
Warming of the ear required 3 3 1 2 1 1 2 1
Changing of lancet required 7 7 - - - - - -
4. Absorption of blood drops 2 5 3 2 - - 2 -
5. Portable blood glucose monitor handling 3 5 3 2 1 - - -
Test strips handling 3 5 4 2 - - - -
* It is possible that a given owner experienced more than one technical problem simultaneously. This explains the discrepancy 
between the numbers in the text and those in the tables. The sum for each step was not always seven, because some owners 
were unable to complete all steps of the procedure. For example, for generation of a negative pressure in cats, two owners were 
unable to complete this step and thus, the reported number is five (see Table 3).
† Never=problem did not occur during sampling
‡ Sometimes=problem occurred two or three times per sampling§ Often=problem occurred more than three times per sampling
\ Always=problem occurred each time when sampling was tried
Repeated instruction and demonstration of the procedure
did not aid the four cat owners who were unsuccessful in
performing a blood glucose curve.
With respect to the whole group, patient resistance to the
blood collection technique appeared during restraint (n=4),
lancing of the skin (n=4), and generation of a negative pres-
sure (n=2) on day 1. On day 2, there was no improvement
in the demeanor of the cats during the procedure. Operation
of the PBGM and test strips generated few problems for the
cat owners. As well, the control measurements were per-
formed once daily without difficulty; all measurements
were within the required range. Overall procedure evalua-
tion in the cats studied and incidence of technical problems
are provided in Tables 2 and 3, respectively.
Glucose Measurements
A total of 77 blood glucose measurements were done in
dogs, and 35 were done in cats. In four instances (four dif-
ferent animals: two dogs and two cats), the PBGM regis-
tered “lo” (low, <1.1 mmol/L), which was attributed to an
insufficient amount of blood. In the dogs studied, the blood
glucose concentrations obtained during glucose curves
ranged between 1.9 and 5.4 mmol/L (median, 3.7 mmol/L).
Three (3/77, 4%) glucose measurements were <2.8 mmol/L
(1.9 mmol/L [n=2], 2.2 mmol/L [n=1]).
In the cats of this study, the blood glucose concentra-
tions obtained during glucose curves ranged between 1.8
and 4.1 mmol/L (median, 3.3 mmol/L). Three (9%) mea-
surements were <2.8 mmol/L (1.8 mmol/L, 2.6 mmol/L,
2.7 mmol/L). Glucose concentrations were evaluated statis-
tically in those six animals (four dogs and two cats) in
which both glucose curves were obtained. There was no
statistically significant difference between days 1 and 2.
Discussion
The concept of home monitoring of blood glucose concen-
tration in dogs and cats stemmed from the experience in
human medicine where it has gained wide acceptance in the
management of diabetic individuals. The collection of cap-
illary blood from the ear of diabetic dogs and cats and the
measurement of blood glucose concentration with a PBGM
are performed routinely in the authors’ clinic to determine
blood glucose curves. Previous studies have shown that
there is good correlation between the glucose concentra-
tions of capillary and venous blood.18 For the majority of
veterinarians and veterinary students, the procedure is easy
and quick to perform. An adequate amount of blood can be
obtained relatively easily with the lancet device used
because of the negative pressure created by the device.18
The results of this study indicate that this is also true for
dog owners and some cat owners.
Recent studies have evaluated a variety of different
PBGMs.19-21 The results obtained by them are reasonably
close to those obtained with reference methods, although
some devices are more accurate than others.19-21 For this
study, the authors decided to use the Glucometer Elite
PBGM for several reasons. First, it has been shown in the
authors’ previous studies that blood glucose values obtained
by this PBGM are reasonably close to reference methodol-
ogy.20,21 Second, in contrast to other PBGMs, which may
over- and underestimate the glucose concentrations, the
Glucometer Elite almost always slightly underestimates
them. Therefore, deviations from the reference values are
more calculable than those of other PBGMs.20,21 Third, in
the authors’ experience, the Glucometer Elite is the easiest
PBGM to use, as it has no buttons to press, it turns on auto-
matically when the test strip is inserted, and it requires only
a small amount of blood.18,20,21
To the authors’ knowledge, there are no studies that have
investigated the use of home monitoring of blood glucose
concentrations of dogs and cats by their owners and the
associated potential problems. When instructing the owners,
it is important to stress that an adequate amount of blood is
needed for the PBGM to measure the glucose concentration
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Table 2
Blood Collection and Blood Glucose Concentration Measurement;
Owner Evaluation of Feasibility of the Procedure
Grading Frequency
Dog Cat
Evaluation Grade Day 1 Day 2 Day 1 Day 2
Good 1 1 - 2
Slightly difficult 1 6 2 1
Difficult 2 - - -
Not feasible 3 - 5 4
Note: The grading was done subjectively by the owners.
correctly. The authors theorize that this was the explanation
for those cases in which the PBGM registered “lo.” Addi-
tionally, blood glucose levels were unexpectedly low (<2.8
mmol/L) in six instances. Previous studies have revealed
that a weak point in the measuring procedure using the Glu-
cometer Elite is that an insufficient amount of blood may
result in inaccurate, low readings without giving an error
message.19,20 Therefore, the authors are unable to tell if
those readings of <2.8 mmol/L were due to a handling error
or due to truly low blood glucose concentrations. Recently,
the new generation of Glucometer Elite has been marketed;
this PBGM requires even less blood; therefore, it seems that
this potential problem can be minimized in the future.
In this study, there was a clear difference between the
results of dogs and cats. Most of the dog owners reported
that their pet tolerated blood collection well. All of the dog
owners reported that their technique for blood collection
and use of the PBGM improved quickly and that this led to
an increased confidence in the results. In contrast, only
three of seven cat owners were able to perform one or both
blood glucose curves. These owners also reported that the
procedure became easier to perform after they had gained
some experience. The owners also found that the cats were
more tolerant of blood collection when they were placed in
a favorite spot, such as a windowsill or bed. Interestingly,
the two cats that readily tolerated the procedure were the
only indoor cats of the group. In four of the seven cats, no
blood curve was obtained. For these four cat owners, fur-
ther technical support from their veterinarian did not help,
because the errors were not of a procedural nature. The
problems that were encountered in three of the four cats
were attributed entirely to their disposition. In the fourth
case, bilateral aural hematomas developed, which were
probably attributable to the delicate ear structure of this
breed (i.e., Devon rex). Similar lesions did not occur in any
of the other cats or dogs. In fact, the sites of blood collec-
tion were barely visible and not painful. In contrast to the
dogs, the cats did not become accustomed to the procedure.
With one exception, the collection of blood from cats was
either well tolerated from the start or not tolerated at all.
It is important that owners of diabetic dogs or cats doing
home monitoring have ready access to veterinary support, if
required. Ten of 14 owners called for advice one or more
times, particularly on day 1. Some had specific questions
regarding the procedure, while others wanted reassurance
that they were performing the procedure correctly. After
day 1, two dog owners were discouraged to the point that
they did not want to continue. However, after deliberate dis-
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Table 3
Technical Problems During the Determination of Blood Glucose Concentration in Seven Cats
Incidence of Technical Problem*
Never† Sometimes‡ Often§ Always\
Technical Problem Day 1 Day 2 Day 1 Day 2 Day 1 Day 2 Day 1 Day 2 
1. Restraint required 1 1 1 3 1 - 4 3
Repeated punctures required - 1 2 2 - - 3 1
Resistance to procedure - - 3 4 - 1 4 2
2. Vacuum generation 2 3 2 1 - - 1 -
Repeated punctures required 1 2 - - 1 1 3 1
Accidental repeated punctures 4 4 1 - - - - -
3. Blood drop generation - 3 - 1 4 - 1 -
Warming of the ear required 3 3 1 - - - 1 1
Changing of lancet required 5 4 - - - - - -
4. Absorption of blood drops 3 4 1 - - - - -
5. Portable blood glucose monitor handling 2 3 2 1 - - - -
Test strips handling 2 3 1 1 1 - - -
* See comments from Table 1.
† Never=problem did not occur during sampling
‡ Sometimes=problem occurred two or three times per sampling§ Often=problem occurred more than three times per sampling
\ Always=problem occurred each time when sampling was tried
cussion, they went on to complete the blood glucose
curves without further problems. When support via tele-
phone did not suffice, owners were given additional
detailed explanations and demonstrations at home or in
the clinic. The latter was ideal for immediate identifica-
tion and correction of errors. At the end of the study, all of
the dog owners said that they would perform this proce-
dure on a regular basis if they had a diabetic animal. Three
owners commented that without the extra motivation and
support, which allowed them to successfully complete the
second blood glucose curve, they would have decided dif-
ferently. As expected, only three of the cat owners said
they would perform this procedure on a regular basis;
these were those owners who were able to complete one
or both blood glucose curves.
The prerequisite for good owner instruction is that the
veterinarian himself is able to perform the procedure cor-
rectly and that he is aware of all potential sources of errors.
According to the authors’ results, the most frequently
encountered problems were inadequate formation of a
blood drop due to excessive pressure with the finger on the
pinna during use of the lancet device, repeatedly depress-
ing the plunger of the lancet device instead of allowing the
negative pressure to slowly build up, and failure to fill the
blood glucose test strip up to the mark. These steps of the
procedure need to be stressed and better clarified during
both the explanation and demonstration of this technique.
Frequent reassessment of the technique will also increase
both owner and veterinarian confidence in the results gen-
erated.
Home monitoring of blood glucose concentration in
human diabetics has been performed for many years and
has become the foundation to proper treatment of
diabetics.22 The American Diabetes Association recom-
mends home monitoring of blood glucose concentrations as
an essential part of the management of diabetes melli-
tus.14,15 However, it has long been known that many errors
can occur during home monitoring of blood glucose con-
centrations in humans. The National Steering Committee
for Quality Assurance in Capillary Blood Glucose Monitor-
ing12 emphasized the importance of patient education with
repeated demonstration of the procedures and observation
of the patients as they perform them. They recommended
reassessment of the technique 30 and 180 days after train-
ing and yearly thereafter, or sooner when results indicate
possible procedural error. These recommendations should
be implemented if home monitoring of blood glucose con-
centrations is to be successful in diabetic dogs and cats.
The results of this study identified important causes of
error in collection of capillary blood from the ear and in the
use of the PBGM. The authors have been able to use these
results for better education of owners who want to perform
home monitoring of blood glucose concentrations in dia-
betic dogs and cats. Further studies are in progress to deter-
mine whether home monitoring of blood glucose
concentrations improves the glycemic control of diabetic
dogs and cats.
a Microlet Vaculance; Bayer Diagnostics, Zurich, Switzerland
b Glucometer Elite; Bayer Diagnostics, Zurich, Switzerland
c SPSS/PC V 6.0, Base manual; SPSS Inc., Chicago, IL 1993
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INTRODUCTION
In diabetic dogs and cats, measurement of
blood glucose concentrations and genera-
tion of blood glucose curves are important
elements of glycaemic control (Feldman
and Nelson 1996). Many human diabetics
practise self- or home monitoring, which
means that they determine blood glucose
concentrations themselves (Cohen and
Zimmet 1980, Bergman and Felig 1984,
American Diabetes Association 1996,
1998, Foster and others 1999). Blood is
usually collected from a finger tip using an
automatic lancing device, and blood 
glucose concentration is measured using 
a portable blood glucose meter (PBGM)
(Baum 1996, Girouard and others 2000).
It has been claimed that the ability of
patients to perform frequent and simple
measurements with a PBGM is the most
significant advance in the management of
diabetes since the discovery of insulin
(Watts and Keffer 1989). 
In the past few years, a number of 
studies have investigated the feasibility of
home monitoring of blood glucose con-
centrations in diabetic dogs and cats.
Recently, a method for collecting capillary
blood from the ear of dogs and cats using
an automatic lancing device was reported
(Wess and Reusch 2000a). In addition, it
was shown that glucose concentrations of
capillary blood from the ear correspond
with those of venous blood (Wess and
Reusch 2000a). Evaluation of various
PBGMs showed that their accuracy and
reliability were sufficient for the purpose of
home monitoring (Wess and Reusch
2000b,c). Another recent study demon-
strated that dog and cat owners who had
no previous experience of blood collection
and determination of blood glucose con-
centrations, were able to reliably master
these procedures (Casella and Reusch
2000). 
Until recently, home monitoring was
not routinely performed by owners of 
diabetic animals. Thus, the aims of this
prospective study were: to determine
whether owners of diabetic dogs were will-
ing and able to perform home monitoring 
on a long-term basis, and to assess what
problems were encountered; to compare 
the results of home and hospital blood 
glucose curves; and to compare treatment 
decisions based on home- and hospital-
generated blood glucose curves.
MATERIALS AND METHODS
Selection of dogs
The study was conducted between 1999
and 2000 at the Clinic for Small Animal
Medicine, University of Zurich, Switzer-
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The Royal College of Veterinary Surgeons considers that the taking of a blood sample from an
animal is an act of veterinary surgery. It may lawfully be done in the UK by veterinary surgeons or
veterinary nurses, and by the owners of farm animals, but the owners of small animals only have
power to give them minor medical treatment.
The objective of this study was to investigate whether home
monitoring of blood glucose of diabetic dogs by owners would be
possible on a long-term basis. The owners of 12 diabetic dogs were
each asked to generate four glucose curves by taking capillary
blood samples from their dog’s ear, at three- to four-week intervals.
Within one week of each curve being produced by the owner, an
additional curve was produced by a veterinarian in the hospital. 
Ten owners were able to generate blood glucose curves; three of
them needed a second demonstration, and two telephoned for
further guidance. The blood glucose concentrations obtained from
the first two ‘hospital’ curves were significantly lower than those
measured at home. Overall, in 42 per cent of cases, the treatment
based on the hospital curves would have been different from that
based on ‘home’ curves. The results of this study indicate that 
the majority of owners were able and willing to perform long-term
monitoring of the blood glucose concentrations of their dogs.
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land. Dogs with diabetes mellitus were
included in the study if owners were will-
ing to learn home monitoring techniques,
and to return to the hospital for six re-
evaluations of their dog’s glucose concen-
tration, over a 16-week period. 
Diagnosis of diabetes mellitus was 
based on characteristic clinical signs, which
included polyuria, polydipsia, polyphagia,
weight loss, fasting hyperglycaemia and 
elevated serum fructosamine (>340 µmol/
litre). Twelve dogs aged from five to 13
years (median nine years) and ranging in
weight from 5·1 to 32·0 kg (median 15·5
kg) were used in the study. Nine dogs had
recently been diagnosed with diabetes 
mellitus and three had been treated with
insulin for between two weeks and two
months before the commencement of the
study. There were seven female (all spayed)
and five male (two castrated) dogs. Among
the breeds represented were poodle (three),
Labrador retriever (2), cocker spaniel (two),
Eurasian (one), Border collie (one), Berga-
masker (one), dachshund (one), and one
mixed-breed dog. None of the owners were
familiar with blood collection prior to the
study. Informed owner consent was
obtained in all cases. 
Study design
Diabetes mellitus was diagnosed in nine
dogs in the authors’ clinic and in three
dogs by referring veterinarians. A thorough
physical examination, complete blood
count (CBC), biochemical profile (in-
cluding fructosamine concentration) and 
urinalysis were performed for all dogs. Fur-
ther examinations were performed when
necessary. All dogs received 0·3 to 0·7
IU/kg of an intermediate-acting insulin
(Insulin Novo Lente MC 40; Novo
Nordisk, Küsnacht, Switzerland [11 dogs]
and Caninsulin; Intervet Boxmeer, the
Netherlands [one dog]), subcutaneously
twice daily. The majority of dogs remained
in the authors’ clinic for two days. Blood
glucose concentrations were determined
before the administration of insulin and
then every two hours for a 12-hour period
(seven measurements in total). The dosage
of insulin was adjusted only when hypo-
glycaemia occurred (blood glucose concen-
tration <4 mmol/litre). Two dogs that had
diabetic ketoacidosis at the time of admis-
sion underwent intensive care treatment;
after stabilisation they were treated with an
intermediate-acting insulin at the above-
mentioned dosage. At discharge, owners
received detailed information on various
aspects of diabetes mellitus and were
taught how to inject the insulin. The con-
cept of home monitoring was introduced
for the first time at this stage.
Re-evaluations were scheduled for one,
three, six, nine, 12 and 16 weeks after the
first evaluation and included a detailed his-
tory, physical examination, determination
of haematocrit values and concentrations
of serum fructosamine, albumin and total
protein, and the creation of a blood glu-
cose curve. This involved the measurement
of blood glucose concentrations before the
administration of insulin and then every
two hours for a 12-hour period. The dogs
were fed their usual diet.
At the second re-evaluation (three
weeks after the first examination), each
owner was taught how to monitor their
dog’s glucose levels at home. This process
took a minimum of 30 minutes and 
consisted of repeated demonstrations of
the use of the lancing device and the
PBGM. The owner then performed the
technique once or twice on his or her dog.
Each owner was also taught how to cali-
brate the PBGM and check its accuracy
using the control strip, and how to record
FIG 1. Form on which owners recorded the
blood glucose concentrations of their diabetic
dogs. This example shows the home blood
glucose curve (broken line) and the hospital
blood glucose curve (solid line) from a diabetic,
seven-year-old, 5·7 kg, spayed female poodle.
The dog received 4 IU of an intermediate-acting
insulin twice daily. For each blood glucose
curve, the concentration of blood glucose was
measured before the administration of insulin
and then every two hours for a 12-hour-period.
The two blood glucose curves, which were
determined within one week of each other, 
differ. The home blood glucose curve has a 
nadir of 4·6 mmol/litre, which is considered
good; however, it shows that the efficacy of 
the insulin is too short (effect lasts until 1 pm).
The hospital blood glucose curve has a nadir 
of 2·8 mmol/litre, which is too low, and the
efficacy of the insulin is long (insulin effect lasts
beyond the time of the next injection). Based on
the home blood glucose curve, a longer-acting 
insulin would be required, but based on the 
hospital curve, a reduction in the insulin dosage
would be needed. No change in treatment was made at this point. The next two home blood glucose curves had a nadir of 7·5 and 8·9 mmol/litre. The
insulin dosage was increased by 1 IU, and the polyuria/polydipsia, which was present at the time of the previous curve, resolved. The low glucose nadir
and long efficacy of the insulin in the previous hospital blood glucose curve were attributed to decreased appetite of the dog while in the hospital
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blood glucose concentrations on the pre-
pared forms (Fig 1).
The owners received written instruc-
tions, including photographs, of how to
cary out the home monitoring; a PBGM,
test strips, a lancing device, a chart on
which to record blood glucose measure-
ments, and a questionnaire. They were
asked to produce a blood glucose curve at
home within one week of the next re-
evaluation. They were advised that blood
glucose concentrations should be deter-
mined before the administration of insulin
and then every two hours afterwards for a
12-hour period (seven measurements).
Owners were also asked to fill out a ques-
tionnaire after producing each blood 
glucose curve. At the third re-evaluation
(six weeks after the first evaluation), a vet-
erinarian (M. C.) evaluated and, if neces-
sary, corrected the owner’s technique of
capillary blood collection. When required,
other aspects of the home monitoring
technique were also evaluated at this time.
Insulin dosage was adjusted based on
the glucose nadir: when the nadir was 
<4 mmol/litre, ≥4 and <10 mmol/litre, or
≥10 mmol/litre, the insulin dosage was
decreased, unaltered or increased, respec-
tively. Based on the glucose curves, feeding
times and the timing and duration of exer-
cise were adjusted in some dogs. In most
cases, these decisions were based on the
blood glucose curves derived at the owner’s
home.
Owners produced a total of four blood
glucose curves each, which were referred to
as home curves. A blood glucose curve was
produced in the authors’ hospital within
one week of each home curve being 
produced; these curves were referred to as
hospital curves. Each of the four home
curves was compared to the corresponding
hospital curve. The comparisons were
referred to as the first curve comparison
(weeks 5 and 6 after first evaluation), sec-
ond curve comparison (weeks 8 and 9 after
first evaluation), third curve comparison
(weeks 11 and 12 after first evaluation),
and fourth curve comparison (weeks 15
and 16 after first evaluation). The dosage 
of insulin administered to the dog was
identical for each of the curves that were
compared.
Equipment
The PBGM used in this study was a 
Glucometer Elite and the lancing device
was a Microlet Vaculance (both Bayer
Diagnostics, Zurich, Switzerland).
Collection of capillary blood and
measurement of blood glucose
concentration
Capillary blood collected from the inner
pinna using a lancing device was used for all
blood glucose determinations (Wess and
Reusch 2000a). All blood glucose concen-
trations were measured using a PBGM 
(Fig 2).
Questionnaire
The owner’s questionnaire contained a
total of 18 questions which related to the
following aspects of blood collection and
glucose measurement: restraint of the dog,
generation of negative pressure with the
lancing device, generation of a drop of
blood, absorption of blood, use of 
equipment, the dog’s tolerance of the 
procedure, and opinion on the overall 
feasibility of the procedure (Casella and
Reusch 2000).
Statistical analysis
A descriptive data analysis was used for
describing technical problems encountered
during blood collection. Range and
median were used for the ages and weights
of the dogs. All blood glucose curve data
were analysed using analysis of variance
(ANOVA) for repeated evaluations
(StatView 5·0; SAS Institute, Wangen,
Switzerland). Differences were considered
significant when P<0·05. 
RESULTS
Clinical signs and serum
fructosamine
Clinical signs of diabetes mellitus rapidly
improved during the treatment period. At
the end of the study, 10 owners felt that their
dogs were normal and two felt that 
their dogs had shown a marked improve-
ment. Serum fructosamine concentrations 
decreased during treatment in nine dogs;
remained unchanged in two, and increased
in one. Compared with the initial concen-
tration, serum fructosamine was signifi-
cantly decreased by the time of the first 
curve comparison (six weeks after the first 
evaluation).
Feasibility of home monitoring
Ten out of the 12 owners were able to deter-
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FIG 2. Generation of a
drop of blood from the
inner pinna of a
diabetic dog using
negative pressure
created by a 
Microlet Vaculance.
Generation of
negative pressure is a
critical part of blood
collection from the
ear and can pose a
variety of technical
problems. It is
important to place
the lancing device flat
on the inner pinna and
to avoid excessive
pressure from the
outer pinna. An error often made by owners when first using the lancing device is to repeatedly
depress the plunger, thereby dissipating the negative pressure rather than allowing it to build up
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mine their dog’s blood glucose concentra-
tions. Eight of the 10 owners completed all
four blood glucose curves and two encoun-
tered problems with blood collection ini-
tially, but completed the last three blood
glucose curves successfully. Two out of the
12 owners were unable to perform any
blood glucose measurements because their
dogs did not tolerate the procedure. 
Problems encountered initially by 
owners included: producing the required 
negative pressure with the lancing device
(8/10), restraint of the dog (5/10), produc-
ing a drop of blood (4/10), absorption of
the drop of blood (4/10), and correct use
of the test strips (2/10) and the glucometer
(2/10). However, after practice and with
repeated advice from a veterinarian, most
of these problems were resolved quickly. At
the end of the study, there were still a few
minor problems involving the production
of negative pressure using the lancing
device (3/10), production of a drop of
blood (1/10), and restraint of the dog
(1/10).
Of the 10 owners, home monitoring at
the time of the first curve comparison was
considered not feasible for two, difficult
for one, mostly straightforward for three,
and straightforward for four. At the end 
of the study, this had changed to mostly
straightforward for one owner and straight-
forward for nine. Nine out of the 10 
owners performed blood glucose measure-
ments alone and one owner required
another person to assist for the first three
curves. Of the 10 dogs, five tolerated the
procedure very well from the start of the
study, four became accustomed to the 
procedure during the first day, and one did
not tolerate the procedure for the first
blood glucose curve.
Comparison of home and hospital
blood glucose curves
A total of four comparisons between home
and hospital blood glucose curves were
made. The maximum (±SD) blood glu-
cose concentrations (mmol/litre) in blood 
glucose curves performed in the authors’
hospital and at home, respectively, were
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FIG 3. Box and whiskers plots comparing (A) maximum blood glucose concentrations from home
and hospital blood glucose curves produced from 10 diabetic dogs, and (B) mean blood glucose
concentrations from home and hospital blood glucose curves. The horizontal lines of the box
represent, from bottom to top, the 25th, 50th (median) and the 75th percentiles. The ends 
of the whiskers represent the 10th and the 90th percentiles. Outlying data points are represented 
by open circles. The maximum and mean blood glucose concentrations of the first and second
hospital blood glucose curves were significantly lower than those of the first and second home
curves. *P<0·05
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18·9 ±4·5 and 24·0 ±5·9 for the first curve
comparison; 15·8 ±5·5 and 21·8 ±6·7 for
the second curve comparison; 15·2 ±3·3
and 17·8 ±5·4 for the third curve compari-
son; and 18·5 ±6·5 and 18·9 ±6·9 for 
the fourth curve comparison. The mean
(±SD) glucose concentrations (mmol/litre)
of curves performed in the authors’ hospi-
tal and at home, respectively, were 13·7
±4·9 and 18·1 ±6·0 for the first curve com-
parison; 11·0 ±5·0 and 15·7 ±6·0 for the
second curve comparison; 10·4 ±3·1 and
12·5 ±4·2 for the third curve comparison;
and 13·5 ±5·4 and 13·0 ±4·9 for the fourth
curve comparison. The nadirs (±SD) of
the hospital and home curves, respectively,
were 9·2 ±5·5 and 11·7 ±6·4; 6·9 ±3·4 
and 7·6 ±4·3; 5·3 ±2·8 and 7·4 ±3·2; and
8·5 ±5·1 and 7·3 ±4·7 for the first, second,
third and fourth curve comparisons,
respectively. 
For the first and second curve compar-
isons, the maximum and mean glucose
concentrations were significantly lower for
curves performed in the authors’ hospital
than for those performed at home. 
However, there was no difference between
glucose nadirs. For the third curve com-
parison, the maximum and mean glucose
concentrations of hospital curves tended to
be lower than those of home curves, but
the differences were not significant. For
the fourth curve comparison, the maxi-
mum and mean glucose concentrations
were similar for the hospital and home
curves (Fig 3).
Insulin dosage based on blood
glucose curves
A total of 38 pairs of blood glucose curves
(hospital and home) were analysed to
determine whether the two corresponding
curves would have led to the same or 
to a different clinical decision with regard
to adjustments of insulin dosage. For 
22 pairs, the dosages would have been 
in agreement (Fig 4A) and for 16 they
would have been different. Based on the
home curves, in five of 16 cases the insulin
dosage would have been lowered, 
whereas, on the basis of the hospital
curves, four would have remained
unchanged (Fig 4B) and one would have
been increased (Fig 4C). In seven of 16
other cases, the hospital curve would 
have led to no change, whereas, on the
basis of the home curves, the dosage would
have been lowered in four cases (Fig 
4D) and increased in three (Fig 4E). In 
the remaining four cases, the insulin
dosage would have been increased based
on hospital blood glucose curves and 
left unchanged based on home curves 
(Fig 4F).
DISCUSSION
When the concept of self-monitoring of
blood glucose concentrations in human
diabetics was first introduced in 1961, it
was largely ignored (Knight and Keen
1961). It was not until the late 1970s that
it gained acceptance. Nowadays, self- or
home monitoring is an integral part of 
the management of diabetes mellitus in
humans (American Diabetes Association
1996). To the authors’ knowledge, this is
the first study to show that the monitoring
of blood glucose concentrations of diabetic
dogs can be performed by their owners at
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FIG 4. Graphic representation of the glucose
nadirs determined in all blood glucose
comparisons. The x-axis represents the nadirs
determined in the hospital blood glucose curves
and the y-axis represents the nadirs of the home
blood glucose curves. For 22 of 38 blood
glucose pairs, the decisions regarding
treatment were in agreement (zone A). For 16 
of 38 pairs, the decisions regarding treatment,
based on the two curves, would have differed,
as follows:
zone B: hospital curve, insulin dosage
decreased; home curve, insulin dosage
unchanged
zone C: hospital curve, insulin dosage
decreased; home curve, insulin dosage
increased
zone D: hospital curve, insulin dosage
unchanged; home curve, insulin dosage
decreased
zone E: hospital curve, insulin dosage
unchanged; home curve, insulin dosage
increased
zone F: hospital curve, insulin dosage increased;
home curve, insulin dosage unchanged
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home. Ten out of 12 (83 per cent) owners
of diabetic dogs were willing and able to
collect blood from their dog’s ear using an
automatic lancing device, to measure the
blood glucose concentration using a
PBGM, and to produce blood glucose
curves during a four-month period. Home
monitoring was introduced to owners
gradually; it was mentioned at the first
evaluation, although the procedure was
not described. At that time, the owners
were encouraged to concentrate on under-
standing the disease and on the correct
injection technique for the administration
of insulin. The re-evaluation one week
later again focused on the correct injection
technique and general problems encoun-
tered with the management of their dog’s
diabetes mellitus.
Home monitoring was introduced
three weeks after the first evaluation. It was
felt that, by this time, owners had become
familiar with the disease and understood
the importance of routine determination
of blood glucose concentrations. The
majority of owners were, by then, inter-
ested in determining blood glucose 
concentrations and curves themselves. In
human medicine, it is known that user
technique is the major source of error in
self-monitoring of blood glucose concen-
trations. Thus, monitoring of the tech-
nique by an expert and frequent practice
are of the utmost importance (Skyler and
Cohen 1997). For additional practice,
owners were asked to determine a single
blood glucose concentration at least twice
weekly, in addition to the blood glucose
curves every three to four weeks, but 
the former results were not used in this 
study. The interval of three to four weeks
between re-evaluations that was used in
this study was about half of that used in
other diabetic dogs that were only evalu-
ated in the hospital and not at home. 
Frequent re-evaluations helped the
authors to ensure that the blood collec-
tions and the use of the PBGM were per-
formed correctly, and to answer any
questions that arose. It also enabled them
to compare blood glucose curves per-
formed at home with those performed in
the hospital. At each re-evaluation, owners
were encouraged to contact the hospital via
telephone when problems or questions
arose. At the end of the four-month study,
all 10 owners who performed the proce-
dure successfully were very comfortable
with home monitoring. All owners kept
their PBGMs, and at least once a month
they produced a blood glucose curve
which was faxed to the authors’ clinic and
discussed via telephone. The majority of
owners learned how to interpret the blood
glucose curves during the course of the
study, and were able to suggest adjust-
ments in insulin dosage and/or feeding,
based on these. 
In humans, inadequate blood sample
volumes account for approximately half of
the procedural errors (Fleming 1994). Pre-
liminary studies indicated that the best
method for obtaining capillary blood from
the ear of a dog was with an automatic
lancing device that created negative pres-
sure after the skin was lanced (Wess and
Reusch 2000a). In contrast to other lan-
cing devices, this device produces an ade-
quate volume of blood for use in a PBGM.
However, it also caused most of the prob-
lems encountered during the initial stages
of home monitoring. Owners usually
applied too much pressure on the outer
pinna against the lancing device, thereby
preventing the formation of a sufficiently
large blood drop. In the Eurasian dog, the
small, stiff and very thick ear, with its large
amount of hair, prevented the formation of
adequate negative pressure and thus the
formation of a blood drop. In this dog,
negative pressure was allowed to develop
first without lancing the inner ear. This
created adequate hyperaemia for the device
to be used as normal.
Approximately 50 per cent of owners
were able to perform home monitoring
without further help. For the remaining
owners, telephone advice and/or repeated
demonstrations of the technique in the
authors’ clinic were necessary. As owners
became more confident, the number of
questions decreased. The dogs tolerated
the procedure remarkably well. This was
probably because the procedure was not
painful. In all of the dogs, the inner ear
appeared normal, and lancing sites were
barely visible, even after several blood 
glucose curves had been produced.
The aim of a previous study by Casella
and Reusch (2000) using healthy dogs was
to identify problems encountered by own-
ers performing home monitoring of blood
glucose concentrations. The findings were
used in the present study when teaching
owners home monitoring; particular atten-
tion was paid to the correct formation of
negative pressure in producing a blood
drop using the lancing device. As a result,
owners in this study learned the procedure
of home monitoring much more quickly.
This illustrates that thorough instruction
in the techniques involved in home moni-
toring is very important. The veterinarian
or technician must be familiar with the
technique and all potential problems 
associated with it. Obviously, owners of
diabetic dogs are more motivated to master
the technique than owners of healthy dogs.
Aside from blood collection, the per-
formance of the PBGM and its correct use
are critical for successful home monitor-
ing. Studies in human medicine have
shown that the accuracy of PBGMs can
vary greatly (Trajanoski and others 1996,
Chan and others 1997, Brunner and 
others 1998). The overall reliability of
PBGMs depends on the analytical per-
formance of the instruments, proficiency
of the operator, and the quality of the test
strips (American Diabetes Association
1996). In the past few years, several groups
of investigators have evaluated PBGMs for
use in animals (Joseph and others 1987,
Link and others 1997, Cohn and others
2000, Wess and Reusch 2000b,c). It is,
however, difficult to compare the results of
these studies because different types and
generations of PBGMs were evaluated and
different statistical analyses were used.
In human medicine, error grid analysis
has recently proved to be a useful method
for assessing blood glucose concentrations,
and has gained widespread acceptance
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(Clarke and others 1987, Kabadi and 
others 1994, Brunner and others 1998).
With this method, blood glucose concen-
trations are graphically allocated to five
different zones (zones A to E). Measure-
ments in zone A are clinically accurate,
those in zone B result in benign errors, and
both are clinically acceptable. Measure-
ments in zones C, D and E lead to errors
(of different severity) in the treatment of
the animal and are thus unacceptable.
Error grid analysis was employed in two
veterinary studies which used venous 
and capillary blood to evaluate different
PBGMs, including the one used in this
study. All measurements were in zones A
and B (Wess and Reusch 2000a,b). For the
present study, one of the tested PBGMs
(Wess and Reusch 2000b) that was simple
to use and could be easily placed on the
dog’s ear was chosen to minimise problems
for owners. The Glucometer Elite has no
buttons to press, turns on automatically
when the test strip is inserted, and requires
only a small amount of blood (2 µl), which
is automatically aspirated into the reaction
chamber after contact with the test strip.
(The measurement range of the strip is
11·2 to 33·3 mmol/litre; the result is 
displayed after 30 seconds and the last 20
readings are stored. These readings are 
useful in evaluating the owners’ ability to
correctly read the display.) There are, how-
ever, two important points to remember
when using this PBGM: when an inade-
quate volume of blood is used, the acoustic
tone that normally signals the end of the
measurement still sounds, but the result 
is incorrect (too low) (Wess and Reusch
2000b); and, similar to all PBGMs, the
measurements of the Glucometer Elite
deviate slightly from those of a reference
method. In contrast to other PBGM mea-
surements, which variably over- or under-
estimate reference values, the Glucometer
Elite tends to consistently underestimate
glucose concentrations (Wess and Reusch
2000a,b). This is viewed as an advantage
because the errors are more predictable. 
Previously published reference values
for blood glucose concentrations in
healthy dogs and blood glucose concen-
trations and curves in diabetic dogs have
presumably been determined in clinics or
hospitals, and not at home. These values
may not accurately reflect the actual con-
centrations because of the effects of stress
due to transport to the clinic and being in
an unfamiliar environment, and because 
animals may have a reduced appetite in
hospital which affects blood glucose con-
centrations. In the present study, owners
performed four blood glucose curves at
home over a four-month period. Within
one week of producing each curve at
home, a blood glucose curve was also pro-
duced in the authors’ hospital. Surpris-
ingly, in the first two curve comparisons,
the maximum and mean glucose concen-
trations of the hospital curves were signifi-
cantly lower than those of the home
curves. In the third curve comparison,
there was still a difference but it was not
significant and by the fourth curve com-
parison, the hospital and home curves were
almost identical. The authors had assumed
that, due to stress and reduced activity in
the hospital, the blood glucose concentra-
tions would have been higher than those
measured at home. Reduced appetite thus
appears to be the most probable explana-
tion. Although each owner brought their
dog’s usual food to the hospital, most 
ate only a portion of their normal ration
while in the hospital. This changed by 
the time of the third and fourth hospital
blood glucose curves, when the dogs 
were accustomed to the hospital and staff, 
and appetite remained normal. It was
unlikely that the differences between 
hospital and home blood glucose curves
were attributable to technical errors made
by owners. An inadequate blood volume 
or incorrect placement of the blood drop
on the test strip would both result in 
inaccurate, low blood glucose measure-
ments; this would have led to lower home 
measurements than hospital measure-
ments.
In addition to comparing the home and
hospital curves statistically, the authors
also compared the potential treatment
decisions based on the curve results from
each dog. In 42 per cent of cases, treatment
decisions based on hospital curves differed
from those of home curves. However, in
only 3 per cent would the treatment 
decisions have been reversed (increase ver-
sus decrease of insulin dosage). In the
remaining 39 per cent of cases, the treat-
ment decisions, although different, would
have been of lesser consequence (no
change versus increase or decrease of
insulin dosage). The authors do not know
whether these differences were attributable
to home monitoring. The reproducibility
of glucose curves is difficult to assess
because the glucose concentration may
vary from day to day (Feldman and Nelson
1996, Fleeman and Rand 2001). The lat-
ter study, however, were performed in a
hospital. Further investigation is necessary
to determine whether the reproducibility
of blood glucose curves produced at home
is in fact better than for those produced in
a hospital.
In this study, treatment changes were
usually based on the results of home blood
glucose curves. From the start of the study,
the authors felt that home blood glucose
curves corresponded better with clinical
signs and fructosamine concentrations
than did hospital curves. At the end of the
study, 10 owners (including the two that
did not monitor their dogs at home) felt
that the results of treatment were very
good, and two thought they were satisfac-
tory to good. Whether this high rate of
success was associated with home monitor-
ing remains unknown. Further studies are
underway at the authors’ clinic to deter-
mine whether management of diabetes
mellitus in dogs is improved when home
monitoring is used. The greatest advantage
of home monitoring is that blood glucose
concentration can be measured at any
time. In questionable cases, a number of
individual blood glucose measurements or
blood glucose curves can be generated. In
addition, blood glucose curves performed
at home are likely to more accurately
reflect the efficacy of the insulin dosage
than those performed in a hospital. 
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Conclusions
The results of this study indicate that own-
ers of diabetic dogs are willing and able to
perform long-term home monitoring of
their pet’s blood glucose concentrations. 
A thorough explanation and demonstra-
tion to owners of the home monitoring
techniques is important to minimise 
technical problems. Periodic evaluations of
owner technique are recommended. The
reasons for measuring blood glucose con-
centrations should be explicitly explained
to owners, to avoid confusion and to pro-
vide a better understanding of the manage-
ment of their dog’s diabetes mellitus. 
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Summary  
 
Home-monitoring of blood glucose concentrations by collecting capillary blood from the 
ear of their pet using a lancing device and a portable blood glucose meter has recently 
been introduced to owners. The objectives of this study were to investigate the feasibility 
of home-monitoring of blood glucose in diabetic cats by owners on a long-term basis, the 
problems encountered and to compare glucose concentrations at home with those 
measured in the hospital. Twelve of 15 selected cat owners were able to generate glucose 
curves over the study period of 4 months. Most problems were related to restraining the 
cat, generating negative pressure with the lancing device and producing a blood drop. In 
the majority of cases, these problems could be resolved during the study. Blood glucose 
concentrations in the clinic tended to be lower than at home; some of the differences were 
significant. Overall, in 38% of cases, treatment based on hospital curves would have been 
different from that based on home curves. It is assumed that glucose measurements at 
home are more reliable than those measured in the hospital and that home monitoring 
helps to prevent wrong treatment decisions. 
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Introduction 
 
Serial blood glucose curves (BGCs) are necessary to assess insulin efficacy, glucose 
nadir, time of peak insulin effect, duration of the insulin effect, and degree of fluctuations 
in blood glucose (BG) concentrations. Blood glucose curves are also required to 
recognise the Somogyi phenomenon (Feldman & Nelson 1996). Until recently, the vast 
majority of BGCs were performed in the hospital because most pet owners are unable to 
collect blood samples by venipuncture. However, a variety of problems are associated 
with the determination of BGCs in hospitalised patients. The process is time consuming 
and relatively expensive and therefore, is not performed as frequently as required. Stress 
or lack of food intake can markedly influence BG concentrations. Cats in particular are 
sensitive to stress caused by an unfamiliar environment or by veterinary manipulation. 
Therefore, especially in diabetic cats, in-hospital BGCs can be difficult to interpret or 
may even be useless. 
 In human medicine, it is standard procedure for diabetics to determine their own 
blood glucose concentrations with a portable blood glucose meter (PBGM). Blood is 
usually collected from a fingertip using a lancing device. This so called self-monitoring 
has become an integral part of the management of diabetes mellitus in humans (Cohen & 
Zimmet 1980, Bergman & Felig 1984, American Diabetes Association 1996, 1998, 
Foster et al 1999). 
 Several recent studies have shown that collection of capillary blood using a 
lancing device is possible in dogs and cats, and glucose concentrations determined using 
a PBGM and capillary blood from the ear are in agreement with those of venous blood 
(Wess & Reusch, 2000a, Thompson et al, 2002). Evaluation of various PBGMs showed 
that their accuracy and reliability were sufficient for the purpose of home-monitoring of 
diabetic dogs and cats. (Wess & Reusch 2000 b, c). A number of problems, mostly 
technical in nature, can arise during home-monitoring. However, with experience many 
pet owners overcome these difficulties and perform correct measurements (Casella & 
Reusch 2000, Casella et al 2002). A recent study performed over several months in 
diabetic dogs revealed that in 42% of glucose curves (total of 38 pairs), treatment 
decisions based on BGCs generated in the hospital differed from those generated by the 
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owners at home. In 3% of cases, treatment decisions based on in-hospital BGCs 
completely contradicted those based on BGCs determined at home (Casella et al, 
accepted 2003). 
 To the authors’ knowledge, there are no studies on home-monitoring of blood 
glucose concentrations of diabetic cats by their owners. Therefore, the objectives of this 
study were a) to determine whether owners of diabetic cats are willing and able to 
perform home-monitoring on a long-term basis, b) to determine the types of possible 
problems encountered and c) to compare BGCs generated in the hospital with those 
generated at home by the owner, using the same technique. 
 
 
Materials and methods 
 
Selection of cats 
This prospective study was conducted during the years 1999 and 2000 at the Clinic of 
Small Animal Internal Medicine, University of Zurich, Switzerland. Cats with diabetes 
mellitus were included in the study if their owners were willing to learn home-monitoring 
and to return to our clinic for 6 re-evaluations of their cats over a 16-week period. 
 Diagnosis of diabetes mellitus was based on characteristic clinical signs, fasting 
hyperglycemia and elevated serum fructosamine (>340 µmol/l). Fifteen cats with a 
median age of 11 years (range 5 to 16 years) were included in the study. In 13 cats, 
diabetes mellitus was diagnosed at our clinic. One cat had been treated with insulin for 3 
days and one other for 2 months by the referring veterinarian prior to the study. There 
were four spayed female and 11 castrated male cats. Breeds included domestic shorthair 
cats (n=14) and one Main Coon. Twelve were indoor cats and three were allowed to go 
outside. None of the owners was familiar with blood collection prior to the study. 
Informed owner consent was obtained in all cases.  
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Study design 
A thorough physical examination, complete blood count, biochemical profile (including 
fructosamine and total T4) and urinanalysis were performed in all cats. Further 
examinations were performed when indicated. Cats received an intermediate-acting 
insulin (Caninsulin®, Intervet, Boxmeer, the Netherlands) at a dosage of 0.25 IU/kg 
when fasting BG was <20 mmol/l SC, BID, and 0.5 IU/kg, SC, BID, when fasting BG 
was >20 mmol/l. The majority of cats remained in our clinic for 3 days. Blood glucose 
concentrations were determined before and every 3 hours after administration of insulin 
for a 12-hour period (5 measurements). The dosage of insulin was adjusted only when 
hypoglycemia occurred (BG concentration <3 mmol/l). Six cats that had diabetic 
ketoacidosis and one cat with hypoglycaemia due to insulin over dosage at the time of 
admission underwent intensive treatment; after stabilisation they were treated as 
described above. At discharge, owners received detailed information on various aspects 
of diabetes mellitus and were instructed on how to inject insulin. Also, the concept of 
home-monitoring was introduced to the owner for the first time. 
 Re-evaluations were scheduled 1, 3, 6, 9, 12, and 16 weeks after the first 
evaluation and included a detailed updated history, physical examination and 
measurement of haematocrit and concentrations of serum fructosamine, albumin and total 
protein. A blood glucose curve was obtained by measuring BG concentration before and 
every 2 hours after administration of insulin for a 12-hour period (7 measurements). 
 At the second re-evaluation , each owner was taught the technique of home-
monitoring. This process took a minimum of 30 minutes and consisted of repeated 
demonstrations. The owners then performed the technique once or twice on their pet. 
Each owner was also taught how to calibrate the PBGM, how to check its accuracy using 
the control strip and how to record BG concentrations on prepared forms. 
 Owners received written instructions, which included pictures of the home 
monitoring technique, a PBGM, test strips, a lancing device, a form to record BG 
measurements and a questionnaire. They were asked to perform a blood glucose curve at 
home within 1 week prior to the next re-evaluation. Blood glucose concentrations were to 
be determined before and every 2 hours after administration of insulin for a 12-hour 
period. Owners were also asked to fill in a questionnaire after each BGC (Casella et al 
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2002). At the third re-evaluation (6 weeks after the first evaluation), a veterinarian (MC) 
evaluated and, if necessary, corrected the owner's technique of capillary blood collection. 
When required, other aspects of the home-monitoring technique were also discussed at 
this time. Insulin dosage was adjusted based on the glucose nadir: when the nadir was <5 
mmol/l, from 5 to <9 mmol/l, or ≥9 mmol/l, the insulin dosage was decreased (1 IU/cat), 
remained unchanged or was increased (1 IU/cat), respectively. 
 Owners performed a total of 4 BGCs, which were referred to as home curves. A 
BGC was performed at our clinic within 1 week after each of the home curves; these 
curves were referred to as hospital curves. Each of the 4 home curves was compared to 
the corresponding hospital curve. The comparisons were referred to as the first-curve 
comparison (fifth and sixth weeks after first evaluation), second-curve comparison 
(eighth and ninth weeks after first evaluation), third-curve comparison (11th and 12th 
weeks after first evaluation) and fourth-curve comparison (15th and 16th weeks after first 
evaluation). The dosage of insulin administered was identical for each pair of 
corresponding curves. 
 
Equipment 
The PBGM and lancing device used in this study were the Glucometer Elite and the 
Microlet Vaculance (both from Bayer Diagnostics, Zurich, Switzerland).  
 
Collection of capillary blood and measurement of blood glucose concentration 
Capillary blood was collected from the inner pinna using the lancing device. Blood 
glucose concentrations were measured using the PBGM. The technique was performed as 
previously described (Wess & Reusch 2000a, Reusch et al 2001, Casella et al, 2002, 
2003). For all blood glucose measurements (hospital and home), the same blood 
collecting technique and the same type of PBGM were used (Fig 1). 
 
Data analysis 
A descriptive data analysis was used for describing technical problems encountered 
during blood collection. The general condition of each cat and clinical variables were 
used to assess the efficacy of therapy. A cat was considered stable if it was healthy and 
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interactive at home, had a normal appetite, normal water intake and a stable body weight 
and if the BG concentrations during the day were between 4.5 and 26 mmol/l. A 
difference of 50 µmol/l between the serum fructosamine concentration at the beginning 
and end of the study was defined as clinically relevant, e.g. relevant increase or relevant 
decrease (Reusch et al 1995). 
 Ranges and medians were used to describe the variables age and weight. Blood 
glucose curves that consisted of at least five measurements were compared by analysis of 
variance for repeated measures (Stat View 5.0, SAS Institute, Wangen, Switzerland). 
Differences were considered significant at P<0.05. Box-and-whisker plots were used for 
graphical representation of glucose concentrations. The horizontal lines of the box 
represent, from bottom to top, the 25th, 50th (median) and the 75th percentiles. The ends 
of the whiskers represent the 10th and the 90th percentiles. Outlying data points are 
represented by open circles. 
 
 
Results 
 
Symptoms and serum fructosamine concentrations 
In all cats, symptoms of diabetes mellitus completely or partially subsided during 
treatment. At the end of the study, five cats had no clinical signs of diabetes mellitus and 
were considered to be well stabilized. In seven other cats, water intake was close to 
normal or fluctuated from day to day and they were considered to be satisfactorily to well 
stabilized. Two other cats were not stable despite improvement in symptoms; in both, 
water intake remained elevated. Serum fructosamine concentrations decreased during 
treatment in eight cats, remained unchanged in four, and increased in three cats.  
 
Feasibility of home monitoring 
Twelve of 15 owners were able to determine BG concentrations. Seven of them 
completed all four BGCs. The other five owners encountered problems with blood 
collection: two completed only the last three of four BGCs, two only the last two BGCs 
and one owner performed only the first, third and fourth BGC. Three of 15 owners were 
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unable to perform any BG measurements because their cats did not tolerate the 
procedure. 
 Problems encountered initially included: producing negative pressure with the 
lancing device (11/12), producing a blood drop (10/12), restraining the cat (8/12), 
absorption of the blood drop (4/12) and correct use of the test strips (2/12) and the PBGM 
(2/12). At the end of the study, there were still problems involving restraint of the cat 
(8/12), production of a blood drop (3/12) and the generation of negative pressure using 
the lancing device (2/12). Of the 12 owners who completed the study, home-monitoring 
at the time of the first-curve comparison was considered not feasible or difficult by four, 
mostly straightforward by three and straightforward by one. At the end of the study, 
home monitoring was considered difficult by only one owner, mostly straightforward by 
six and straightforward by five. Ten of the 12 owners performed BG measurements 
without help and two owners always required another person for help. Of the 12 cats, two 
tolerated the procedure very well from the start of the study, five became accustomed to 
the procedure during the first time and five continued to encounter some problems (three 
did not tolerate the procedure well for the first BGC). At the end of the study, four 
tolerated the procedure very well, six became accustomed to the procedure after the first 
or second blood sample of every BGC and two continued to cause problems during the 
collection of blood. 
 In the clinic, two of 12 cats were aggressive making completion of all BGCs 
difficult. In one, the first two BGCs and in the other, the last two BGCs were not 
performed.  
 
Comparison of home and hospital blood glucose curves 
A total of four comparisons between home and hospital BGCs were made. The maximum 
(±SD) BG concentrations (mmol/l) in BGCs performed in the clinic and at home, 
respectively, were 23.8 ± 3.6 and 26.6 ± 2.5 for the first curve comparison, 25.1 ± 5.7 and 
25.4 ± 7 for the second curve comparison, 22.9 ± 6.4 and 22.0 ± 8.3 for the third curve 
comparison, and 21.2 ± 6.8 and 22.7 ± 6.7 for the fourth curve comparison. The mean 
(±SD) glucose concentrations (mmo/l) of curves performed in the clinic and at home, 
respectively, were 19.1 ± 3.9 and 29.3 ± 2.4 for the first curve comparison, 17.6 ± 6.2 and 
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17.8 ± 6.4 for the second curve comparison, 13.7 ± 6.2 and 15.9 ± 6.9 for the third curve 
comparison, and 13.4 ± 6 and 16.8 ± 6.3 for the fourth curve comparison (Fig2A). The 
nadirs (±SD) of the hospital and home curves, respectively, were 14.8 ± 4.8 and 13.8 ± 4, 
12.2 ± 5.6 and 10.6 ± 6.6, 7.5 ± 6 and 10.5 ± 6, and 6.7 ± 5 and 11.2 ± 6.1 for the first, 
second, third and fourth curve comparisons, respectively (Fig. 2B).  
 The minimum glucose concentrations in the third and fourth curve comparisons 
and the mean glucose concentration in the fourth curve comparison were significantly 
lower for curves performed in the hospital than for those performed at home. There was 
no difference between maximum glucose concentrations measured in the hospital and at 
home. 
 
Insulin dosage based on blood glucose curves 
A total of 37 pairs of BGCs (hospital and home) were analysed to determine whether the 
two corresponding curves would have led to a different clinical decision with regard to 
adjustments of insulin dosage. Of 37 hospital curves, 29 were complete (all seven BG 
measurements), six had six BG measurements and two had five BG measurements. Of 37 
home curves, 32 were complete (all seven BG measurements) and five had six BG 
measurements. Decisions regarding insulin dosage would have been in agreement in 23 
pairs of BGCs (Fig. 3A) and would have differed in 14. Based on the results of home 
BGCs, no change in insulin dosage would have been instituted in nine of 14 cats (Fig 3 
B, F), whereas on the basis of hospital curves, the insulin dosage would have been 
decreased in six cats (Fig. 3 B) and increased in 3 (Fig. 3F). In four other cases, the 
insulin dosage would have been increased based on home BGCs (Fig. 3 C+E), whereas 
on the basis of hospital BGCs, the insulin dosage would have remained unchanged in two 
cats (Fig 3E) and decreased in two (Fig. 3C). In the one remaining case, the insulin 
dosage would have been decreased based on the home BGC and increased based on the 
hospital BGC (Fig. 3G). 
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Discussion 
 
80% (12 of 15) of the owners of diabetic cats in our study were willing and able to 
perform a series of BGCs at home over a period of four months. In a previous study, only 
43% (3 of 7) of owners of healthy cats were able to perform the same tasks during a 
shorter study period (Casella et al 2002). Possibly, owners of ill cats are more motivated 
to overcome the problems associated with home-monitoring with the hope that their pet 
will benefit from their efforts. For example, many owners devised strategies for easier 
restraint of their cat and reported that the cat tolerated blood collection better when 
placed in a favourite spot, such as a windowsill or bed or in a confined area such as a 
sink. The present study lasted longer and possibly gave owners more time to become 
proficient at the technique of home-monitoring. Furthermore, in comparison to the 
healthy cats, the diabetic cats seemed to cooperate substantially better during the 
procedure of blood collection. This may be because the diabetic cats were older than the 
healthy cats and with the exception of one, were exclusively indoor cats. 
 The success of home-monitoring hinges greatly on careful preparation and 
instruction of the owner. The technique of home-monitoring was first introduced to all 
owners three weeks after the initiation of treatment in our clinic. This time frame allowed 
owners to become familiar with the disease and with administration of insulin. Re-
assessments were carried out frequently (every three or four weeks) so that the owners' 
technique could be evaluated often and corrected when necessary. 
 Three of 12 owners were immediately able to generate BGCs at home. Technical 
errors were corrected via telephone for two owners. However, additional demonstrations 
of the technique in our clinic were necessary for seven owners. In human medicine, the 
importance of patient education with repeated demonstrations and observation of patient 
technique is emphasised in a study of The National Steering Committee for Quality 
Assurance in Capillary Blood Glucose Monitoring (1993). It has been shown that most 
errors in self-monitoring of blood glucose concentration are associated with blood 
collection or use of the PBGM (Fleming 1994). It is also important to minimise any 
technical difficulties for pet owners. In the present study, the Glucometer Elite was 
selected as the easiest PBGM on the market to operate: it has no buttons to press, turns on 
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automatically when the test strip is inserted and requires only a small amount of blood (2 
µl), which is automatically aspirated into the reaction chamber after contacting the test 
strip. Studies in humans have shown that the accuracy of PBGMs can vary greatly 
(Brunner et al 1998, Trajanoski et al 1996, Chan et al 1997). In the past few years, 
several groups evaluated PBGMs for use in animals using a variety of different statistical 
procedures (Joseph et al 1987, Link et al 1997, Cohn et al 2000, Wess & Reusch 
2000b,c). In human medicine, error grid analysis has gained widespread acceptance for 
the assessment of blood glucose measurements (Clarke et al 1987, Kabadi et al 1994, 
Brunner et al 1998). Two recent veterinary studies that used error grid analysis 
demonstrated that glucose measurements of canine and feline blood samples using 
different PBGMs were in clinically acceptable ranges (Wess & Reusch 2000b,c). In 
contrast to other PBGMs, which over- or underestimated glucose concentrations, the one 
used in the present study consistently underestimated blood glucose concentrations (Wess 
& Reusch 2000b,c). This is considered an advantage because the errors are more 
predictable. Because collection of blood via venipuncture is beyond the scope of an 
average pet owner, a method for collection of capillary blood using a special lancing 
device (Microlet Vaculance) was recently developed. This device creates a negative 
pressure, which facilitates collection of an adequate amount of blood from the ear of cats 
and dogs (Wess & Reusch 2000a). An important prerequisite for blood collection is 
correct handling of the lancing device so that it actually creates a vacuum. This can be 
difficult and is linked to most of the technical problems (Casella & Reusch 2000, Casella 
et al 2002). In our experience, this problem can be overcome by repeated demonstrations 
and practice. 
 Interestingly, the minimum glucose concentrations in the third- and fourth-curve 
comparisons and the mean glucose concentration in the fourth-curve comparison were 
significantly lower for hospital curves. In fact, we had assumed that due to stress caused 
by an unfamiliar environment, veterinary manipulation and reduced physical activity 
during the stay in the clinic, the BG concentrations would be elevated. Cats are 
considered particularly sensitive to stress (Leidinger et al 1989, Opitz 1990, Feldman & 
Nelson 1996). However, a plausible reason for lower BG values in hospitalised patients is 
that they frequently refuse to eat. In a similar study of diabetic dogs, a decrease in food 
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intake was believed to be the most likely explanation for lower BG concentrations in 
hospitalised dogs compared to dogs evaluated at home (Casella et al 2003). It is unlikely 
that the differences were attributable to technical errors made by owners at home, 
because an inadequate amount of blood would have resulted in an erroneous low BG 
measurement (Wess & Reusch 2000b, c). We do not know why there was no such 
difference between the BGCs in the first two curve comparisons, but we hypothesise that 
it was due to stress-related hyperglycaemia overriding a decrease of BG due to lack of 
food intake at the beginning of the study in cats in the clinic.  During the course of study, 
the stress caused by the blood collection may have diminished as cats became 
accustomed to the procedure, although not to the point where they felt comfortable 
enough to eat. However, it is impossible to determine the role of stress in this study. 
Physiological stress is difficult to define in animals. Recently, a study attempted to 
characterise the changes in BGCs in cats exposed to an acute stressor and to determine 
the associations between BG and behavioural indicators of stress in stress 
hyperglycaemia (Rand et al 2002). It was demonstrated that there is a strong relationship 
between increased BG and fear responses of cats and that the nature of the stressor 
influences the severity of hyperglycaemia. That study, however, was performed in 
healthy cats, and it is currently not known whether the findings also apply to sick or 
diabetic cats. 
 In addition to comparing home and hospital curves statistically, we also compared 
the potential treatment decisions based on BGCs of each cat. In 14/37 (38 per cent) of the 
cases (case = one pair of BGCs, treatment decisions based on hospital curves differed 
from those of home curves; in three cases, the treatment decisions would have been 
completely contrary and in the remaining 11 cases, they would have differed, although 
with little clinical consequence. In ten of 14 cases, the insulin dosage based on the 
hospital curve would have been lower than that based on the home curve. We do not 
know whether these differences were attributable to home-monitoring. Blood glucose 
curves are known to vary from day to day (Feldman & Nelson 1996). Similarly, Fleeman 
& Rand (2003) reported that in diabetic dogs, BGCs determined in the clinic on 
successive days varied widely. Studies are currently underway in our clinic to compare 
the reproducibility of BGCs performed at home and in the clinic.  
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  In the present study, the insulin dosage chosen was based largely on the results of 
home BGCs. We feel that the home environment is the least stressful and that BGCs 
performed there reflect the glycaemic status better than those performed in the clinic. 
Therefore, home BGCs may allow for a better control of the disease. Another advantage 
is that home curves can be carried out as frequently as required. In complicated cases, 
more than one BGC can be performed at home before a decision is made concerning 
therapy. 
 The results of this study indicate that owners of diabetic cats are willing and able 
to perform long-term monitoring of BG concentrations. At the end of the study, the 
majority of owners could not only evaluate the results of testing but also dose the insulin 
correctly. All 12 owners involved in this study elected to keep the PBGM. They 
communicated with the clinic on a regular basis, and presently, discuss treatment based 
on home BGCs via telephone or fax at least once a month. This built a close relation 
between client and veterinarian and provided a good basis for successful control and 
treatment of the disease. Periodic evaluations of the owners' technique are required and 
the targeted blood glucose concentrations should be explicitly defined to avoid confusion 
and to provide a better understanding of the management goals. 
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Legends to figures 
 
Figure 1 
Capillary blood sampling from the pinna of a cat by use of a lancing device (Microlet 
Vaculance)  
 
Figure 2 
(A) Comparison of mean blood glucose concentrations of home and hospital blood 
glucose curves of 12 cats with diabetes mellitus. 
(B) Comparison of glucose nadirs of home and hospital blood glucose curves of 12 cats 
with diabetes mellitus. 
 
The mean blood glucose concentrations of the fourth hospital curve and the minimal 
blood glucose concentrations of the third and fourth hospital curves were significantly 
lower compared to the corresponding home curves. 
 
blood glucose concentrations determined in the clinic = black; at home = stippled  
* P<0.05 
 
Figure 3  
Graphic representation of the glucose nadirs for all blood glucose comparisons. The x-
axis represents values from hospital curves and the y-axis represents values from home 
curves. In 23 of 37 blood glucose pairs, the decisions regarding treatment were in 
agreement (zone A). In 14 of 37 pairs, the decision regarding treatment differed in one of 
five different ways: 
Zone B; hospital curve: decrease insulin; home curve: insulin unchanged 
Zone C; hospital curve: decrease insulin; home curve: increase insulin 
Zone D; hospital curve: insulin unchanged; home curve: decrease insulin 
Zone E; hospital curve: insulin unchanged; home curve: increase insulin 
Zone F; home curve: increase insulin; home curve: insulin unchanged 
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Figure 4  
Two blood glucose curves (BGCs), generated either at home (broken line) or in the clinic 
(solid line) in a 7-year-old, castrated male, domestic shorthair cat. For each BGC, the 
blood glucose concentration was measured before and every 2 hours after administration 
of insulin during a 12-hour period for a total of 7 measurements. The two BGCs, 
generated within one day of each other, differ. 
(A) Third re-evaluation. The cat is on 7 IU Caninsulin BID and still showed polydipsia 
and polyuria. The home BGC has a nadir of 19.9 mmol/l, which is too high, and thus, an 
increase in the insulin dosage would be advised. The hospital BGC has a nadir of 4.1 
mmol/l, which is considered borderline, and a reduction in the insulin dosage might be 
advised. The final decision was based on the home curve and the insulin dosage was 
increased to 9 IU, BID. 
(B) Forth re-evaluation. The cat is on 9 IU Caninsulin BID. Polydipsia and polyuria are 
still present but have improved. The home BGC had a nadir of 15.6 mmol/l and the 
hospital BGC a nadir of 1.6 mmol/l. Based on the hospital and home curves, the insulin 
dosage would be reduced and increased, respectively. The insulin dosage was kept 
unchanged and the owner was asked to generate another BGC a week later. The low 
glucose nadirs in the hospital BGC were attributed to decreased food intake during 
hospitalisation. The home BGC one week later (not shown) had again a nadir >9 mmol/l 
and the owner increased the insulin dosage to 10 IU, BID. Since then the cat is doing well 
and clinical signs have normalized. 
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